GZ402665
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Genzyme, a Sanofi Company
Overview
GZ402665 is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
GZ402665 clinical trials
Explore related
Medical disclaimer. This page summarizes research about GZ402665 for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.